Drug Trial Radar · NCT07355296
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
132
Planned (sponsor's estimate)
Start
Mar 23, 2026
Primary completion
Jan 20, 2028
Study completion Feb 17, 2028
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Jan 21, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults with certain kidney conditions, including secondary focal segmental glomerulosclerosis (sFSGS), treatment-resistant primary minimal change disease (TR-pMCD), Alport Syndrome (AS), and treatment-resistant primary membranous nephropathy (TR-pMN). Adolescents with treatment-resistant primary MCD can also participate in this study. The purpose of this study is to find out whether a medicine called BI 764198 helps people with these kidney conditions. Participants are put into 2 groups randomly, which means by chance. One group takes BI 764198 tablets, and the other group takes placebo tablets. Placebo tablets look like BI 764198 tablets but do not contain any medicine. Participants take a tablet once a day for 20 weeks. All participants also continue their standard medication for their kidney condition during the study. Participants have twice the chance of being placed in the BI 764198 group than in the placebo group. Participants are in the study for about 7 months. During this time, they visit the study site 6 times and have 3 phone calls. Doctors regularly test the protein levels in participants' urine by collecting urine samples. They also check kidney function by taking blood samples. The results are compared between the two groups to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.
Conditions
- Proteinuric Kidney Diseases
Interventions
BI 764198Drug
BI 764198
Placebo matching BI 764198Drug
Placebo matching BI 764198
Primary outcomes
What the sponsor says the trial is designed to measure.
- Relative change from baseline to Week 20 in 24-hr Urine protein-to-Creatinine Ratio (UPCR)Time frame: At baseline and week 20
Locations
153 sites in 32 countries. Site status is shown where the registry gives one.
Nephrology Consultants, LLC
Huntsville, Alabama · Recruiting
Kidney Disease Medical Group
Glendale, California · Recruiting
Amicis Research Center - Balboa
Granada Hills, California · Recruiting
Academic Medical Research Institute - Glendale
Los Angeles, California · Recruiting
University of California Los Angeles
Los Angeles, California · Not yet recruiting
Colorado Kidney Care
Denver, Colorado · Recruiting
Florida Kidney Physicians - Boca Raton
Boca Raton, Florida · Recruiting
Florida Kidney Physicians, LLC - Fort Lauderdale
Fort Lauderdale, Florida · Recruiting
Total Research Group, LLC
Miami, Florida · Recruiting
CTR Oakwater, LLC
Orlando, Florida · Recruiting
Florida Kidney Physicians - Riverview/Brandon
Riverview, Florida · Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · Not yet recruiting
Endeavor Health
Evanston, Illinois · Recruiting
Johns Hopkins Hospital
Baltimore, Maryland · Recruiting
St. Clair Nephrology Research, LLC - Shelby Township
Shelby, Michigan · Recruiting
New York Nephrology and Dialysis Access Surgery, PC
Clifton Park, New York · Recruiting
NYU Langone Nephrology Associates-Mineola
Mineola, New York · Recruiting
Duke University Medical Center
Durham, North Carolina · Not yet recruiting
Cleveland Clinic
Cleveland, Ohio · Not yet recruiting
Nationwide Children's Hospital
Columbus, Ohio · Not yet recruiting
Northeast Clinical Research Center
Bethlehem, Pennsylvania · Recruiting
Southeast Renal Research Institute
Chattanooga, Tennessee · Recruiting
Provecta Researh Network
Houston, Texas · Recruiting
West Virginia University Medicine
Morgantown, West Virginia · Recruiting
Terapia Renal Domiciliaria
Buenos Aires, Argentina · Recruiting
Centro Medico Dra Laura Maffei
Ciudad Autonoma Buenos Aires, Argentina · Recruiting
Clinica Privada Velez Sarfield
Córdoba, Argentina · Recruiting
CardioAlem Investigaciones
San Isidro, Argentina · Recruiting
Concord Repatriation General Hospital
Concord, New South Wales, Australia · Not yet recruiting
Nepean Hospital
Kingswood, New South Wales, Australia · Recruiting
John Hunter Hospital
New Lambton Heights, New South Wales, Australia · Recruiting
Royal Brisbane and Women's Hospital
Brisbane, Queensland, Australia · Recruiting
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia · Recruiting
AZORG Ziekenhuis
Aalst, Belgium · Recruiting
Az Maria Middelares Gent
Ghent, Belgium · Recruiting
UZ Leuven
Leuven, Belgium · Recruiting
Universidade Federal do Ceara
Fortaleza, Brazil · Recruiting
Hospital de Clinicas de Porto Alegre
Porto Alegre, Brazil · Recruiting
Fundacao Oswaldo Ramos (Hospital do Rim)
São Paulo, Brazil · Recruiting
Hospital das Clinicas da Faculdade de Medicina da USP
São Paulo, Brazil · Recruiting
Showing 40 of 153 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.